PRIMARY MEDIASTINAL (THYMIC) LARGE B-CELL LYMPHOMA
Clinical trials for PRIMARY MEDIASTINAL (THYMIC) LARGE B-CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new PRIMARY MEDIASTINAL (THYMIC) LARGE B-CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for PRIMARY MEDIASTINAL (THYMIC) LARGE B-CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New chemo dosing shows promise for kids with rare cancers
Disease control CompletedThis study tested a new way of giving chemotherapy called dose-adjusted EPOCH-R in children with certain B-cell cancers (DLBCL, PMBCL, or PTLD). The goal was to see if it is safe and could improve cure rates while reducing side effects, as it has in adults. Only 4 children took p…
Matched conditions: PRIMARY MEDIASTINAL (THYMIC) LARGE B-CELL LYMPHOMA
Phase: EARLY_PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
New combo therapy shows promise for tough lymphoma cases
Disease control CompletedThis study tested a combination of pembrolizumab (an immunotherapy drug) and targeted radiation in 17 patients with non-Hodgkin lymphoma that had returned or stopped responding to treatment. The goal was to see if adding radiation could help the immune system fight the cancer bet…
Matched conditions: PRIMARY MEDIASTINAL (THYMIC) LARGE B-CELL LYMPHOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 13, 2026 16:00 UTC